MELLOW PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MELLOW PHARMA
Largest movements
- Cash +€83,875
up €83,875 (+59.6%), from €140,631 to €224,506
mainly Other debts (+€164,035) and Net result for the year (+€101,364)
- Tangible fixed assets -€16,349
down €16,349 (-31.2%), from €52,481 to €36,132
of which Leasing and similar rights: -€14,904
- Other debts +€164,035
up €164,035 (+8437.7%), from €1,944 to €165,980
- Reserves -€63,937
down €63,937 (-23.7%), from €269,889 to €205,952
- Debts after one year -€54,109
down €54,109 (-23.8%), from €227,551 to €173,442
- Tax, wage and social debts +€26,824
up €26,824 (+136.8%), from €19,615 to €46,439
of which Taxes: +€26,824
- Gross operating margin +€46,060
up €46,060 (+40.2%), from €114,679 to €160,739
- Taxes +€11,315
up €11,315 (+45.9%), from €24,675 to €35,990
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €616,087 | €690,049 | +€73,963 | +12.0% |
| Fixed assets | 21/28 | €442,481 | €426,132 | -€16,349 | -3.7% |
| Tangible fixed assets | 22/27 | €52,481 | €36,132 | -€16,349 | -31.2% |
| Furniture and vehicles | 24 | €4,101 | €2,656 | -€1,445 | -35.2% |
| Leasing and similar rights | 25 | €48,380 | €33,476 | -€14,904 | -30.8% |
| Financial fixed assets | 28 | €390,000 | €390,000 | = | 0.0% |
| Current assets | 29/58 | €173,606 | €263,918 | +€90,312 | +52.0% |
| Amounts receivable within one year | 40/41 | €32,014 | €38,661 | +€6,648 | +20.8% |
| Trade receivables | 40 | €31,985 | €38,661 | +€6,676 | +20.9% |
| Other amounts receivable | 41 | €29 | €0 | -€29 | -100.0% |
| Cash at bank and in hand | 54/58 | €140,631 | €224,506 | +€83,875 | +59.6% |
| Deferred charges and accrued income | 490/1 | €961 | €750 | -€210 | -21.9% |
| Total equity and liabilities | 10/49 | €616,087 | €690,049 | +€73,963 | +12.0% |
| Equity | 10/15 | €309,889 | €245,952 | -€63,937 | -20.6% |
| Contributions | 10/11 | €40,000 | €40,000 | = | 0.0% |
| Reserves | 13 | €269,889 | €205,952 | -€63,937 | -23.7% |
| Distributable reserves | 133 | €269,889 | €205,952 | -€63,937 | -23.7% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €306,197 | €444,097 | +€137,900 | +45.0% |
| Amounts payable after more than one year | 17 | €227,551 | €173,442 | -€54,109 | -23.8% |
| Financial debts | 170/4 | €227,551 | €173,442 | -€54,109 | -23.8% |
| Amounts payable within one year | 42/48 | €78,378 | €270,430 | +€192,052 | +245.0% |
| Current portion of amounts payable after more than one year | 42 | €56,258 | €57,331 | +€1,073 | +1.9% |
| Financial debts | 43 | - | €46 | +€46 | |
| Credit institutions | 430/8 | - | €46 | +€46 | |
| Trade debts | 44 | €561 | €635 | +€74 | +13.2% |
| Suppliers | 440/4 | €561 | €635 | +€74 | +13.2% |
| Taxes, remuneration and social security | 45 | €19,615 | €46,439 | +€26,824 | +136.8% |
| Taxes | 450/3 | €17,598 | €44,422 | +€26,824 | +152.4% |
| Remuneration and social security | 454/9 | €2,016 | €2,016 | = | 0.0% |
| Other amounts payable | 47/48 | €1,944 | €165,980 | +€164,035 | +8437.7% |
| Accrued charges and deferred income | 492/3 | €268 | €224 | -€44 | -16.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €16,189 | €16,349 | +€160 | +1.0% |
| Other operating charges | 640/8 | €2,459 | €2,102 | -€357 | -14.5% |
| Non-recurring operating charges | 66A | €189 | €0 | -€189 | -100.0% |
| Gross operating margin | 9900 | €114,679 | €160,739 | +€46,060 | +40.2% |
| Operating profit (loss) | 9901 | €95,842 | €142,288 | +€46,446 | +48.5% |
| Financial income | 75/76B | €0 | €0 | +€0 | |
| Recurring financial income | 75 | €0 | €0 | +€0 | |
| Financial charges | 65/66B | €5,512 | €4,934 | -€579 | -10.5% |
| Recurring financial charges | 65 | €5,512 | €4,934 | -€579 | -10.5% |
| Profit (loss) for the period before taxes | 9903 | €90,330 | €137,355 | +€47,025 | +52.1% |
| Income taxes | 67/77 | €24,675 | €35,990 | +€11,315 | +45.9% |
| Profit (loss) for the period | 9904 | €65,655 | €101,364 | +€35,710 | +54.4% |
| Profit (loss) for the period to be appropriated | 9905 | €65,655 | €101,364 | +€35,710 | +54.4% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 1 October 2026 via checked.be.